Logo image of GRWG

GROWGENERATION CORP (GRWG) Stock Fundamental Analysis

NASDAQ:GRWG - Nasdaq - US39986L1098 - Common Stock - Currency: USD

1.01  +0.03 (+3.23%)

After market: 1.0004 -0.01 (-0.95%)

Fundamental Rating

3

Taking everything into account, GRWG scores 3 out of 10 in our fundamental rating. GRWG was compared to 123 industry peers in the Specialty Retail industry. GRWG has a great financial health rating, but its profitability evaluates not so good. GRWG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

GRWG had negative earnings in the past year.
In the past year GRWG has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: GRWG reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: GRWG reported negative operating cash flow in multiple years.
GRWG Yearly Net Income VS EBIT VS OCF VS FCFGRWG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

GRWG's Return On Assets of -30.48% is on the low side compared to the rest of the industry. GRWG is outperformed by 88.62% of its industry peers.
GRWG has a worse Return On Equity (-45.03%) than 65.85% of its industry peers.
Industry RankSector Rank
ROA -30.48%
ROE -45.03%
ROIC N/A
ROA(3y)-34.55%
ROA(5y)-19.87%
ROE(3y)-47.9%
ROE(5y)-27.71%
ROIC(3y)N/A
ROIC(5y)N/A
GRWG Yearly ROA, ROE, ROICGRWG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

GRWG has a Gross Margin of 26.92%. This is in the lower half of the industry: GRWG underperforms 69.92% of its industry peers.
GRWG's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for GRWG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.68%
GM growth 5Y-0.74%
GRWG Yearly Profit, Operating, Gross MarginsGRWG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

7

2. Health

2.1 Basic Checks

GRWG does not have a ROIC to compare to the WACC, probably because it is not profitable.
GRWG has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, GRWG has more shares outstanding
There is no outstanding debt for GRWG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GRWG Yearly Shares OutstandingGRWG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
GRWG Yearly Total Debt VS Total AssetsGRWG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

GRWG has an Altman-Z score of -0.67. This is a bad value and indicates that GRWG is not financially healthy and even has some risk of bankruptcy.
GRWG's Altman-Z score of -0.67 is on the low side compared to the rest of the industry. GRWG is outperformed by 83.74% of its industry peers.
There is no outstanding debt for GRWG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.67
ROIC/WACCN/A
WACC8.87%
GRWG Yearly LT Debt VS Equity VS FCFGRWG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

GRWG has a Current Ratio of 4.38. This indicates that GRWG is financially healthy and has no problem in meeting its short term obligations.
GRWG's Current ratio of 4.38 is amongst the best of the industry. GRWG outperforms 95.94% of its industry peers.
GRWG has a Quick Ratio of 2.69. This indicates that GRWG is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.69, GRWG belongs to the top of the industry, outperforming 95.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.38
Quick Ratio 2.69
GRWG Yearly Current Assets VS Current LiabilitesGRWG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

3

3. Growth

3.1 Past

GRWG shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.33%.
Looking at the last year, GRWG shows a very negative growth in Revenue. The Revenue has decreased by -18.56% in the last year.
The Revenue has been growing by 18.83% on average over the past years. This is quite good.
EPS 1Y (TTM)-6.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.29%
Revenue 1Y (TTM)-18.56%
Revenue growth 3Y-23.54%
Revenue growth 5Y18.83%
Sales Q2Q%-25.44%

3.2 Future

Based on estimates for the next years, GRWG will show a very strong growth in Earnings Per Share. The EPS will grow by 28.47% on average per year.
GRWG is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -10.35% yearly.
EPS Next Y47.18%
EPS Next 2Y28.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-16.82%
Revenue Next 2Y-10.35%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GRWG Yearly Revenue VS EstimatesGRWG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
GRWG Yearly EPS VS EstimatesGRWG Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

GRWG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GRWG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GRWG Price Earnings VS Forward Price EarningsGRWG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GRWG Per share dataGRWG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

GRWG's earnings are expected to grow with 28.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.47%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GRWG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GROWGENERATION CORP

NASDAQ:GRWG (8/4/2025, 8:10:04 PM)

After market: 1.0004 -0.01 (-0.95%)

1.01

+0.03 (+3.23%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-11 2025-08-11/amc
Inst Owners41.42%
Inst Owner Change1.01%
Ins Owners7.54%
Ins Owner Change4.45%
Market Cap60.09M
Analysts77.78
Price Target1.91 (89.11%)
Short Float %4.19%
Short Ratio3.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-78.65%
Min EPS beat(2)-141.38%
Max EPS beat(2)-15.91%
EPS beat(4)0
Avg EPS beat(4)-64.55%
Min EPS beat(4)-141.38%
Max EPS beat(4)-15.91%
EPS beat(8)0
Avg EPS beat(8)-66.16%
EPS beat(12)2
Avg EPS beat(12)-58.57%
EPS beat(16)3
Avg EPS beat(16)-44.61%
Revenue beat(2)0
Avg Revenue beat(2)-10.43%
Min Revenue beat(2)-11.68%
Max Revenue beat(2)-9.18%
Revenue beat(4)2
Avg Revenue beat(4)-4.31%
Min Revenue beat(4)-11.68%
Max Revenue beat(4)3.08%
Revenue beat(8)4
Avg Revenue beat(8)-1.78%
Revenue beat(12)6
Avg Revenue beat(12)-0.52%
Revenue beat(16)7
Avg Revenue beat(16)-0.11%
PT rev (1m)0%
PT rev (3m)-39.19%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-24.99%
EPS NY rev (1m)0%
EPS NY rev (3m)-12.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.37%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.34
P/FCF N/A
P/OCF N/A
P/B 0.54
P/tB 0.59
EV/EBITDA N/A
EPS(TTM)-0.84
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS2.97
BVpS1.87
TBVpS1.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.48%
ROE -45.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.92%
FCFM N/A
ROA(3y)-34.55%
ROA(5y)-19.87%
ROE(3y)-47.9%
ROE(5y)-27.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.68%
GM growth 5Y-0.74%
F-Score4
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.62%
Cap/Sales 1.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.38
Quick Ratio 2.69
Altman-Z -0.67
F-Score4
WACC8.87%
ROIC/WACCN/A
Cap/Depr(3y)41.94%
Cap/Depr(5y)91.22%
Cap/Sales(3y)2.88%
Cap/Sales(5y)3.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.29%
EPS Next Y47.18%
EPS Next 2Y28.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.56%
Revenue growth 3Y-23.54%
Revenue growth 5Y18.83%
Sales Q2Q%-25.44%
Revenue Next Year-16.82%
Revenue Next 2Y-10.35%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-22.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.53%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-167.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-111.22%
OCF growth 3YN/A
OCF growth 5YN/A